AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,000 | -20.0% | 2,777 | -15.8% | 0.00% | – |
| Q2 2023 | $10,000 | +233.3% | 3,299 | +179.6% | 0.00% | – |
| Q1 2023 | $3,000 | +50.0% | 1,180 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | -33.3% | 1,180 | +18.0% | 0.00% | – |
| Q3 2022 | $3,000 | -82.4% | 1,000 | -78.3% | 0.00% | – |
| Q2 2022 | $17,000 | -37.0% | 4,600 | -32.4% | 0.00% | – |
| Q1 2022 | $27,000 | -56.5% | 6,800 | -46.3% | 0.00% | – |
| Q4 2021 | $62,000 | -38.0% | 12,659 | -15.0% | 0.00% | – |
| Q3 2021 | $100,000 | -16.0% | 14,898 | -0.7% | 0.00% | – |
| Q2 2021 | $119,000 | -39.0% | 15,004 | -41.4% | 0.00% | – |
| Q1 2021 | $195,000 | +4775.0% | 25,583 | +2711.3% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 910 | +381.5% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 189 | -61.5% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 491 | +94.1% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 253 | -41.2% | 0.00% | – |
| Q1 2019 | $2,000 | – | 430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 11,297,911 | $55,925,000 | 5.88% |
| Prosight Management, LP | 1,248,453 | $6,180,000 | 3.43% |
| PA Capital LLC | 76,257 | $377,000 | 0.37% |
| Artal Group S.A. | 1,000,000 | $4,950,000 | 0.20% |
| Temasek Holdings (Private) Ltd | 2,614,095 | $12,940,000 | 0.10% |
| COHEN LAWRENCE B | 13,350 | $66,000 | 0.04% |
| Tekla Capital Management LLC | 171,813 | $850,000 | 0.04% |
| Athanor Capital, LP | 108,540 | $537,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 28,600 | $142,000 | 0.02% |
| APPLETON PARTNERS INC/MA | 11,525 | $57,000 | 0.01% |